…development of anti-PD-L1 as the first generation of immunotherapy to combat Alzheimer's disease, and searching for novel CNS specific checkpoint targets as the second generation of immunotherapy. They are specifically going after discovering novel antibodies in partnership with Lundbeck. Cellular Rejuvenation Therapy and Biomarker Development Dr. Shai Efrati Lab: http://www.assafh.org/sites/en/clinic/Hifrbaric/Pages/default.aspx Hyperbaric medicine was originally conceptualized to ameliorate the effects of air embolism in deep water divers. Dr…